This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
EU Financial accounts reports
Go to paperABSTRACT: Presents updates on the 2000 financial results of several biotechnology and pharmaceutical firms in Eu…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Conflict of interest in academic research
Go to paperABSTRACT: The potential for conflict of interest in research can occur whenever a faculty member’s …

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
A new season for biotechnology in Europe
Go to paperABSTRACT: Comments on the status of the biotechnology industry in Europe as of March 2002. Research s…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Welcome to Biotech Nation
Go to paperABSTRACT: Welcome to Biotech NationMoira A. Gunn, PhDAMACOM, New York, NY;ISBN: 978 0814409237; 2007; 258pp; hardbac…

Gerry Langeler, author of The Success Matrix and Managing Director with OVP Venture Partners recently spoke at a breakfast event and was kind

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The legal and ethical considerations relating to the supply and use of human tissue for biomedical research: A UK perpective
Go to paperABSTRACT: Alder H…

I will be presenting at Bioinnovation 2014 in Gdansk, Poland on October 20-21st. My talk will cover entrepreneurship and business

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Embryo and stem cell research: Views from the USA
Go to paperABSTRACT: Presents a study that examined the history, ethical debates and religious views r…

In this article, we look at how patent filings in three key areas of genome-related research indicate the direction of private and public research in sequencing technology, personalised medicine and synthetic biology. Patent landscaping allows for anal…